Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics (England 2020-05-21)

TrumpLyftAlles | 5 points | Nov 23 2020 20:25:42

Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics (England 2020-05-21)

https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.1909